ESTABLISHED 2024 A CIVIC RECORD OF ACTIONS TAKEN AGAINST THE AMERICAN PEOPLE — AND HOW WE RESTORE THEM April 16, 2026
A nonpartisan civic restoration project

UndoTrump.com

★   ★   ★

Tracking every rollback, reversal, and overreach — and the path back to the America we know.

975
Actions Tracked
755
Still Active
27
In the Courts
24
Restored
451
Days Tracking

Results for "healthcare"

11 Actions  ·  Page 1 of 2
Active

Executive Order 14235: Restoring Public Service Loan Forgiveness

On March 7, 2025, President Trump signed Executive Order 14235 to restore the Public Service Loan Forgiveness (PSLF) program. The order reinstates loan forgiveness eligibility for federal employees, teachers, healthcare workers, and other public service workers who meet program requirements. The confirmed direct impact is that eligible borrowers in public service occupations regain access to loan forgiveness after 10 years of qualifying payments.

Active

Executive Order 14216: Expanding Access to In Vitro Fertilization

On February 18, 2025, President Trump signed Executive Order 14216 directing federal agencies to expand access to in vitro fertilization (IVF) services. The order instructs relevant agencies to remove regulatory barriers and increase IVF availability through federal health programs and supported facilities. The confirmed direct impact includes expanded IVF coverage eligibility and reduced administrative obstacles for Americans seeking fertility treatment through federally-supported healthcare.

Active

President's Make America Healthy Again Commission established

Executive Order 14212 was signed on February 13, 2025, establishing the President's Make America Healthy Again Commission. The order creates a commission to develop policy recommendations related to public health and healthcare. The confirmed direct impact on Americans includes the creation of a new advisory body that will issue reports and recommendations on health policy, though implementation of any recommendations would require further action.

Active

Executive Order enforcing Hyde Amendment restrictions on federal abortion funding

On January 24, 2025, President Trump signed Executive Order 14182 directing federal agencies to enforce the Hyde Amendment, which prohibits federal funds from being used to pay for abortion services except in cases of rape, incest, or danger to the mother's life. The order requires agencies to withhold federal funding from any organization that provides, refers for, or covers abortion services. The confirmed direct impact includes potential loss of federal funding for Planned Parenthood and other healthcare providers that offer abortion services alongside other medical care.

Active

Mexico City Policy reinstated; federal funding restrictions on abortion

On January 24, 2025, the Trump administration signed Memorandum 2025-02176 reinstating the Mexico City Policy, which prohibits federal funding to international non-governmental organizations that provide abortion services, counseling, or referrals. The policy immediately rescinds Biden administration guidance that had lifted the restriction in 2021. The confirmed effect is that U.S. foreign aid to global health organizations will be conditioned on their non-involvement in abortion services, reducing funding available to NGOs that currently provide comprehensive reproductive healthcare internationally.

Active

Executive Order 14179: Removing Barriers to American Leadership in Artificial Intelligence

President Trump signed Executive Order 14179 on January 23, 2025, directing federal agencies to remove regulatory barriers to artificial intelligence development and deployment. The order establishes a framework for accelerating AI innovation through reduced compliance requirements and streamlined approval processes across federal agencies. Confirmed direct impacts include expedited AI project approvals in federal programs and modified regulatory timelines for AI systems in healthcare, transportation, and other sectors.

Active

Memorandum freezing federal regulatory actions pending review

On January 20, 2025, the Trump administration signed Memorandum 2025-01906 directing a freeze on pending federal regulatory actions. The freeze halts the issuance and effective date of regulations that have not yet taken effect. The immediate effect is that dozens of pending rules across federal agencies are suspended pending review, affecting regulatory implementation timelines across healthcare, environmental, labor, and financial sectors.

Active

Executive Order on Gender and Biological Sex in Federal Government

President Trump signed Executive Order 14168 on January 20, 2025, directing federal agencies to recognize only two biological sexes and eliminate federal recognition of gender identity beyond biological sex. The order affects federal employee policies, healthcare services, and agency guidance regarding sex and gender classifications. Confirmed impacts include changes to federal employee benefits, healthcare coverage determinations, and how federal agencies process sex-based classifications.

Active

Federal Support for National Guard COVID-19 Response Operations

On April 20, 2020, President Trump signed a memorandum directing continued federal funding and support for governors' deployment of National Guard units to respond to COVID-19 and support economic recovery efforts. The memorandum authorized the Department of Defense to provide financial assistance, equipment, and logistical support for state-activated National Guard personnel engaged in pandemic response activities. This action enabled states to utilize National Guard resources for tasks including testing, contact tracing, distribution of medical supplies, and support to healthcare facilities without states bearing the full operational costs.

Active

Executive Order 13877: Healthcare Price and Quality Transparency

Executive Order 13877 was signed on June 24, 2019, requiring hospitals to publicly disclose standard charges for items and services, and requiring health insurers to disclose negotiated rates and out-of-pocket costs to patients. The order directed the Department of Health and Human Services to establish rules requiring price transparency. Confirmed effects include: hospitals began publishing price lists (though compliance varied and many lists remained difficult to access), and insurers incrementally increased availability of cost-estimation tools, though widespread patient access to negotiated rates was limited during the Trump administration.